Clofarabine
  
Side effects 
	
		
Options: 
			
			Show MedDRA Preferred Terms
		
	
	
| Side effect | Data for drug | Placebo | Labels | 
|  | 1 | 2 | 
| Leukopenia | 87.7% |  | x |  | 
| Lymphopenia | 82.3% |  | x |  | 
| Thrombocytopenia | 79.8% - 80.7% |  | x | x | 
| Anaemia | 75.4% - 83.3% |  | x | x | 
| Neutropenia | 63.7% |  | x |  | 
| Alanine aminotransferase increased | 43.4% - 80.5% |  | x | x | 
| Aspartate aminotransferase increased | 36% - 74% |  | x | x | 
| Vomiting | very common, 59% |  | x | x | 
| Bilirubin total increased | 13.2% - 44.7% |  | x |  | 
| Creatinine increased | 7.8% - 49.5% |  | x | x | 
| Rash | 21% |  | x | x | 
| Tachycardia | common, 35% |  | x | x | 
| Headache | very common, 24% |  | x | x | 
| Diarrhoea | very common, 20% |  | x | x | 
| Pruritus | very common, 20% |  | x | x | 
| Body temperature increased | very common, 19% |  | x | x | 
| Nausea | very common |  | x | x | 
| Fatigue | very common, 14% |  | x | x | 
| Anxiety | very common, 12% |  | x | x | 
| Flushing | very common, 11% |  | x | x | 
| Mucosal inflammation | very common, 11% |  | x | x | 
| Abdominal pain | common |  | x | x | 
| Alopecia | common |  |  | x | 
| Anorexia | common |  | x | x | 
| Arthralgia | common |  | x | x | 
| Back pain | common |  | x | x | 
| Bacteraemia | common |  | x | x | 
| Oral candidiasis | common |  | x | x | 
| Chest wall pain | common |  |  | x | 
| Contusion | common |  |  | x | 
| Cough | common |  |  | x | 
| Dehydration | common |  |  | x | 
| Dizziness | common |  |  | x | 
| Dyspnoea | common |  | x | x | 
| Oedema | common |  | x | x | 
| Epistaxis | common |  | x | x | 
| Gingival bleeding | common |  |  | x | 
| Haematemesis | common |  |  | x | 
| Haematoma | common |  |  | x | 
| Haematuria | common |  | x | x | 
| Herpes simplex | common |  | x | x | 
| Herpes zoster | common |  | x | x | 
| Hyperbilirubinaemia | common |  | x | x | 
| Hyperhidrosis | common |  |  | x | 
| Hypersensitivity | common |  | x | x | 
| Hypotension | common |  | x | x | 
| Irritability | common |  | x | x | 
| Jaundice | common |  | x | x | 
| Multi-organ failure | common |  |  | x | 
| Mouth haemorrhage | common |  | x | x | 
| Pain | common |  | x | x | 
| Pain in extremity | common |  | x | x | 
| Paraesthesia | common |  |  | x | 
| Pericardial effusion | common |  | x | x | 
| Neuropathy peripheral | common |  |  | x | 
| Petechiae | common |  | x | x | 
| Pneumonia | common |  | x | x | 
| Prurigo | common |  | x | x | 
| Proctalgia | common |  | x | x | 
| Septic shock | common |  | x | x | 
| Stomatitis | common |  | x | x | 
| Tremor | common |  |  | x | 
| Tumour lysis syndrome | common |  | x | x | 
| Erythema | common |  | x | x | 
| Weight decreased | common |  |  | x | 
| Chills | common |  | x | x | 
| Agitation | common |  | x | x | 
| Oedema peripheral | common |  |  | x | 
| Mouth ulceration | common |  |  | x | 
| Bone pain | common |  | x | x | 
| Dry skin | common |  |  | x | 
| Skin hyperpigmentation | common |  |  | x | 
| Myalgia | common |  | x | x | 
| Tachypnoea | common |  | x | x | 
| Decreased appetite | common |  |  | x | 
| Abdominal pain upper | common |  | x | x | 
| Rash erythematous | common |  |  | x | 
| Skin exfoliation | common |  |  | x | 
| Systemic inflammatory response syndrome | common |  | x | x | 
| Sepsis | common |  | x | x | 
| Capillary leak syndrome | common |  | x | x | 
| Rash maculo-papular | common |  |  | x | 
| Respiratory distress | common |  | x | x | 
| Rash generalised | common |  |  | x | 
| Generalised erythema | common |  |  | x | 
| Venoocclusive disease | common |  |  | x | 
| Feeling abnormal | common |  |  | x | 
| Somnolence | common |  | x | x | 
| Feeling hot | common |  |  | x | 
| Toxic epidermal necrolysis | postmarketing |  | x | x | 
| Gastrointestinal disorder | postmarketing |  | x | x | 
| Gastrointestinal haemorrhage | postmarketing |  | x | x | 
| Stevens-Johnson syndrome | postmarketing |  | x | x | 
| Unspecified disorder of skin and subcutaneous tissue | postmarketing |  | x | x | 
| Exfoliative conditions | postmarketing |  | x | x | 
| Asthenia |  |  | x |  | 
| Bacterial infection |  |  | x | x | 
| Mental disorder |  |  | x | x | 
| Bone disorder |  |  |  | x | 
| Candida infection |  |  | x |  | 
| Cellulitis |  |  | x |  | 
| Cholelithiasis |  |  |  | x | 
| Colitis |  |  |  | x | 
| Infection |  |  | x | x | 
| Connective tissue disorder |  |  | x |  | 
| Cyst |  |  | x | x | 
| Enterocolitis |  |  |  | x | 
| Cardiac disorder |  |  | x | x | 
| Haemorrhage |  |  |  | x | 
| Hypertension |  |  | x |  | 
| Immune system disorder |  |  | x | x | 
| Influenza |  |  | x |  | 
| Renal failure acute |  |  |  | x | 
| Lethargy |  |  | x |  | 
| Mediastinal disorder |  |  | x | x | 
| Fungal infection |  |  | x |  | 
| Necrosis |  |  |  | x | 
| Neoplasm |  |  | x | x | 
| Nervous system disorder |  |  | x | x | 
| Pancreatitis |  |  | x | x | 
| Pancytopenia |  |  |  | x | 
| Pericarditis |  |  |  | x | 
| Pleural effusion |  |  | x |  | 
| Pneumonia mycoplasmal |  |  | x |  | 
| Polyp |  |  | x | x | 
| Pulmonary oedema |  |  | x | x | 
| Renal failure |  |  |  | x | 
| Respiratory syncytial virus infection |  |  | x |  | 
| Sinusitis |  |  | x |  | 
| Staphylococcal infection |  |  | x |  | 
| Upper respiratory tract infection |  |  | x |  | 
| Urinary tract disorder |  |  | x | x | 
| Angiopathy |  |  | x | x | 
| Viral infection |  |  |  | x | 
| Cholecystitis acute |  |  |  | x | 
| Hepatocellular injury |  |  |  | x | 
| Staphylococcal bacteraemia |  |  | x |  | 
| Malnutrition |  |  | x | x | 
| Fatal outcomes |  |  |  | x | 
| Hepatotoxicity |  |  | x |  | 
| Blood creatinine increased |  |  | x |  | 
| Oral mucosal petechiae |  |  | x |  | 
| Clostridium difficile colitis |  |  |  | x | 
| Caecitis |  |  | x | x | 
| Hepatobiliary disease |  |  | x | x | 
| Parainfluenzae virus infection |  |  | x |  | 
| Blood bilirubin increased |  |  |  | x | 
| Pneumonia fungal |  |  | x |  | 
| Gastroenteritis adenovirus |  |  | x |  | 
| Prolonged menses |  |  |  | x | 
| Nephropathy toxic |  |  | x | x | 
| Hyperuricaemia |  |  | x | x | 
| Fungal sepsis |  |  | x |  | 
| Febrile neutropenia |  |  | x |  | 
| Infestation NOS |  |  | x | x | 
| Blood and lymphatic system disorders |  |  | x | x | 
| Ear and labyrinth disorders |  |  |  | x | 
| Escherichia sepsis |  |  | x |  | 
| Enterococcal bacteraemia |  |  | x |  | 
| Hypotensive |  |  |  | x | 
| Catheter related infection |  |  | x | x | 
| Escherichia bacteraemia |  |  | x |  | 
| Clostridium colitis |  |  | x |  | 
| Respiratory failure |  |  |  | x | 
| Death |  |  |  | x | 
| Hearing impaired |  |  |  | x | 
	 
 
  Indications
	Information about indications was extracted from the indications and usage sections of the labels.
	
 
	  
	  
		| Side effects: | 116 | 
|---|
		| Source: | FDA Structured Product Label | 
|---|
		 
	  
	  
		| Side effects: | 135 | 
|---|
		| Source: | EMA | 
|---|
		 
	  
  
 
  
	Color scheme:
	  
	  standard – alternative
	  
	
	
|  |  | 100% | 
|  |  | 75% | 
|  |  | 50% | 
|  |  | 10% | 
|  |  | frequent (1% to 100%) | 
|  |  | infrequent (0.1% to 1%) | 
|  |  | rare (<0.1%) | 
|  |  | postmarketing | 
|  |  | 0% | 
|  |  | no frequency information | 
|  |  | not found on label |